ELISA Kit Accurately Detects Bioactive Hepcidin Levels

Hepcidin has been identified as a factor in regulating the amount of iron in humans and unbalanced iron level can lead to many common medical conditions including anemia and iron overload disease, and can occur in chronic kidney disease, inflammation, or diabetes mellitus.

The new Hepcidin 25 (bioactive) HS ELISA kit has an analytical sensitivity of 0.153 ng/mL, with a measuring range of 0 81 ng/mL to 153 ng/mL. Serum or plasma samples can be assessed and the total incubation time is less than two hours. The ELISA is user-friendly as no shaker and no assay buffer is required, and all reagents except wash solution are ready-to-use.

The new DRG Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit is manufactured by DRG International (Springfield Township, NJ, USA) and is more sensitive that their previous product for measuring hepcidin. The DRG Hepcidin 25 (bioactive) HS ELISA Kit is available worldwide, providing a simple, fast and accurate method to test hepcidin levels. The measurement results of this kit offer more information to help treat medical issues including iron deficiency diseases, which are some of the most common diseases worldwide. The ELISA kit is Conformité Européenne (CE) marked.

Cyril E. Geacintov, PhD, founder, president and CEO of DRG International, said, “We at DRG International saw the need for an accurate and easy to use hepcidin testing kit and are encouraged by the great success that our customers have seen using the product. This kit is an important step to meet the rapidly growing worldwide interest in hepcidin testing and the applications of that testing in the health and wellness community.”

The new Hepcidin ELISA kit was showcased at the American Association for Clinical Chemistry (AACC) annual meeting held from July 27-30, 2015, in Atlanta (Georgia, USA).

Related Links:
DRG International